patent/EP-1181932-A3

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1181932-A3

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d269c8e41f178194d858c230c9f85e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
filingDate	2001-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffe3b682b99a7de9192952fd891912bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38cbf59486cf72e1e1004f6fd25d7b9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_634a5d0e2fd45a5b0cf61152ccb01a83
publicationDate	2003-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EP-1181932-A3
titleOfInvention	Therapeutic compositions comprising excess enantiomer of amlodipine
abstract	The present invention is concerned with pharmaceutical compositionsncomprising a mixture of amlodipine enantiomers, which compositions havenboth anti-hypertensive and additional cardiovascular properties derivednrespectively from their calcium channel-blocking activity and their ability tonrelease vascular nitric oxide (NO).
priorityDate	2000-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9505822-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0754043-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9310779-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414324

Total number of triples: 41.